| European Case Law Identifier: | ECLI:EP:BA:1991:T013090.19910228 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 28 February 1991 | ||||||||
| Case number: | T 0130/90 | ||||||||
| Application number: | 82303197.6 | ||||||||
| IPC class: | C12P 1/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | |||||||||
| Download and more information: |
|
||||||||
| Title of application: | Recombinant monoclonal antibodies | ||||||||
| Applicant name: | The Board of Regents, Texas | ||||||||
| Opponent name: | 1) Hybritech Incorpor. 2) AKZO Pharma B.V. |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Novelty (yes), after amendment Product produced by cultivation of a trioma - or quadroma cell Inventive step (yes) Auxiliary requests by the Appellant and by the Respondent correspond in substance |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t900130eu1.html
Date retrieved: 17 May 2021